Anthropic’s anticipated debut on Wall Street is viewed by Aegon AM as a milestone that extends far beyond the scope of a single listing. If the company hits the market with a valuation of up to $1.4 trillion, as suggested by the asset manager, the transaction would become a concrete test of investors’ willingness to support the valuations assigned to the artificial intelligence economy.

Its financial significance would not depend solely on the potential size of the IPO. A debut of these proportions would force the market to measure itself against a company whose value reflects exceptionally high expectations for the future development of AI, its commercial adoption, and the sector’s ability to convert massive investments into financial returns. At a time when AI is already one of the primary drivers of attention on the US stock market, the price investors would be willing to pay for Anthropic would send a clear signal to the industry as a whole.

In commentary authored by Jordy Hermanns, Investment Strategist and Portfolio Manager, and Jacob Vijverberg, Head of Asset Allocation at Aegon AM, the listing is therefore framed as a potential test of the confidence underpinning the theme. The reference to the $1.4 trillion threshold highlights the scale of their reasoning: this is not a routine public fundraising round, but an event capable of shifting expectations and risk perception around artificial intelligence companies.

The market evaluates expectations, not just the new stock

A mega-IPO concentrates into a few days a debate that typically unfolds over time. On one side are the growth prospects attributed to the company coming to market; on the other, actual investor demand and their tolerance for high multiples. In the case of Anthropic, according to Aegon AM, this comparison would assume a systemic dimension for the AI segment, as the deal’s valuation would be interpreted as a gauge of confidence in the sector’s broader growth narrative.

This does not mean that the performance of a single stock can sum up a vast and diverse industry. Companies exposed to AI have different business models, revenues, costs, and market positionings. However, markets often use the most visible events as benchmarks. An enthusiastically received outcome could bolster sentiment toward the sector; conversely, a downward revision of valuations could foster greater caution toward assets considered most exposed to the theme.

For the stock market, the issue also concerns the concentration of attention and capital on a few large players. The arrival of a company valued in the trillions would broaden the pool of listed companies tied to the AI economy and make the debate over the sustainability of market capitalizations even more central. Aegon AM does not present this scenario as a definitive forecast on the outcome of the transaction, but underscores its significance as a test for the convictions already priced in.

The potential impact on indices and portfolios

The second element highlighted by the asset manager concerns international equity indices. If Anthropic were to gradually enter the main baskets, its presence could alter their composition and thereby indirectly affect portfolios that track those benchmarks. This is a significant point, as indices are not merely indicators tracked in financial newscasts: they serve as the operational reference for a substantial portion of managed savings and passive investments.

Any eventual inclusion is not automatic and would depend on the rules of individual index providers, eligibility requirements, and the timelines established by their respective methodologies. Yet the scale projected for Anthropic would make the issue hard to overlook. A large market capitalization can secure substantial weight in benchmarks, driving purchases by funds and instruments tracking their composition. For millions of investors, therefore, the transaction could carry consequences even without an active decision to invest directly in the stock.

This mechanism warrants attention especially when a company debuts on the stock market with high expectations. Indices can amplify an issuer's visibility and relevance, while the trajectory of its valuation can influence the distribution of sector weightings. In the scenario outlined by Aegon AM, Anthropic could become one of the nodes through which the relationship between thematic AI investments and global portfolio construction runs.

This dynamic also affects how performance is interpreted. When a handful of large companies exert an increasing influence on benchmarks, index returns can more heavily reflect the swings of those specific names. For those investing through index funds, ETFs or benchmark-linked mandates, the issue is not just the growth opportunity associated with AI, but also the resulting degree of exposure within instruments perceived to be broadly diversified.

Big tech holdings under scrutiny

Aegon AM also points to a possible transmission channel toward tech companies that hold stakes in the sector. Any potential downward revision in valuations would not only affect sentiment around artificial intelligence: it could also impact the reported earnings of companies holding stakes in firms across the sector.

This aspect is significant because it ties the transaction to balance sheets already closely monitored by the market. Valuations of equity holdings can contribute to how financial results and the soundness of major tech platforms' investment strategies are interpreted. If the market were to recalibrate its expectations for AI companies, the comparison would not stop at Anthropic's price: it would extend to investee companies' ability to maintain valuations aligned with those reflected in corporate investors' portfolios.

For this reason, a public listing would serve an informational role that goes beyond raising capital or providing liquidity to shareholders and investors. The market would gain a publicly available reference point, traded daily, to gauge a core part of the artificial intelligence cycle. Yet an essential limitation remains: a stock market price is the synthesis of shifting expectations and does not equate to a definitive verdict on the industrial outlook of the company or the sector.

The gap with Europe remains evident

In the geographical comparison proposed by Aegon AM, Europe presents a different structure from the United States. Trillion-dollar listings are absent from the European market, and IPOs tend to be more modest in size. This reduces the likelihood that a single newcomer could, on its own, carry weight comparable to what is envisioned for Anthropic on US exchanges and in global benchmarks.

However, the asset manager cautions against turning this difference into an analytical shortcut. A market with fewer mega-cap companies is not necessarily one with lower return potential. According to Aegon AM, European equities are more diversified, and the mere presence of massive corporations is not a sufficient indicator of performance prospects. For European investors, the message is twofold: monitor Anthropic’s IPO for its potential international repercussions, without using the scale of US champions as the sole yardstick to judge the continent's stock exchanges.

The next phase will depend on the transaction's details and the market's response. As long as valuation, listing terms, and investor demand remain to be determined, it is premature to infer definitive impacts on indices and portfolios. Yet the point raised by Aegon AM is already clear: in the current market cycle, Anthropic could become a prime vantage point for seeing how much capital is still willing to back the promises of artificial intelligence.

Sources